Richard A. Graham - Mar 14, 2023 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, RESEARCH & DEVELOPMENT
Signature
/s/ Corinna Liebowitz, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Mar 14, 2023
Transactions value $
-$23,973
Form type
4
Date filed
3/16/2023, 07:04 PM
Previous filing
Mar 8, 2023
Next filing
Apr 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Sale -$24K -2.32K -0.62% $10.32 372K Mar 14, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.